Privacy

Cookie Policy

Contact

Home

ABOUT

Editorial

PRESS RELEASES

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR

SUBSCRIBE

Market Reports

FDA

Executives

Funding

Non Profits

Hospitals

Acquisitions

Health

Biotechnology News Magazine

HomeProton Radiotherapy Treatment

Proton Radiotherapy Treatment

RaySearch and Mevion to Develop Next-Generation Treatment Planning Techniques for FLASH Proton Radiotherapy Treatment

RaySearch Laboratories AB (publ) and Mevion Medical Systems, two companies that are leading the field of proton therapy, announce a collaboration to develop advanced treatment planning techniques for FLASH delivery with the MEVION S250i Proton Therapy System.

C-RAD Is Selected At 3 U.S. Proton Cancer Treatment Centers

C-RAD Sentinel 4DCT™ is an easy-to-use, laser-based optical surface scanning system with functionality for four-dimensional CT image reconstruction and gated imaging in a CT room.

With Second Mevion Proton System Installed at Siteman Cancer Center, Additional Cancer Patients Begin Treatment

The newest addition to the S. Lee Kling Proton Therapy Center features Mevion’s industry-leading HYPERSCAN® technology and Adaptive Aperture® pMLC. HYPERSCAN provides faster and more precise targeted dose delivery to tumors and minimizes the damage to surrounding healthy tissue and sensitive organs at risk.

Synchrocyclotron for the MEVION S250i Proton Therapy System Delivered to Huntsman Cancer Institute

The proton center at Huntsman Cancer Institute at the University of Utah will be the first in the Mountain West.

Proton Beam Therapy Significantly Lowers Risk of Side Effects, Reveals Major Study

The study by the University of Pennsylvania, the first of its kind, evaluated data on 1,483 patients, 391 of whom received proton beam therapy and 1,092 who received photon (conventional radiation) treatment.

Beacon Hospital Treats First Patient in Malaysia on Varian Halcyon System

4/2/19: Varian Halcyon simplifies and enhances virtually every aspect of image-guided volumetric intensity-modulated radiotherapy (IMRT), including improved patient comfort and shortening the time from installation to first-treatment without sacrificing quality.

Allcure Kangtai Selects Mevion Compact Proton Therapy System to Equip Hospital in Southwest China

Mevion notes they are the first company to innovate this new approach to proton therapy and continues to transform the industry and patient care with HYPERSCAN Pencil Beam Scanning.

Varian Installs Gantry for ProBeam Compact Proton Therapy System at New Treatment Center in Singapore

The Varian ProBeam Compact system is a single-room system equipped with a 360-degree gantry for intensity modulated proton therapy.

First Cancer Patients in Taiwan Treated with Varian HyperArc High-Definition Radiotherapy

1/17/19: HyperArc™ High Definition Radiotherapy (HDRT) is a new type of radiosurgery treatment solution reports Varian.

Ackerman Cancer Center Celebrates 1,000 Patients Treated with Proton Therapy

10/16/18: “One of the core values of Ackerman Cancer Center is to ensure patients have access to the most effective and innovative cancer therapies available. Through the use of Proton Therapy, our physicians have witnessed better tolerance in patient treatments, excellent overall outcomes and healthier patients post treatment,” said Scot Ackerman, MD, Medical Director of Ackerman Cancer Center.

Varian Signs Partnership Agreement with Mediheal to Support Cancer Care in Kenya

9/7/18: "Supplying equipment is only part of the solution," said Varian president and CEO, Dow Wilson. "By partnering with a visionary hospital network like Mediheal, we seek to address the entire cancer care continuum, from human capacity development to treatment to long-term sustainability."

Varian Installs ProBeam Cyclotron at UCLH Proton Beam Therapy Center

6/19/18: "Building a proton therapy center in the middle of a large city like London is a construction and logistical challenge and we are very pleased to have reached this important milestone," said Moataz Karmalawy, PhD, general manager of Varian's Particle Therapy division.

By using this website you agree to accept Medical Device News Magazine Privacy Policy